Now, as senior principal and global client service partner at consulting firm EY, he is doing the same thing with artificial intelligence (AI). It’s a skill that serves him well as a member of the ...

A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory ...

New! Sign up for our free email newsletter.